This chitosan can also transfer siP53 directly to the kidneys of AKI mouse models that have been subjected to cisplatin and bilateral ischemia‐reperfusion injury, in which AKI is treated by P53 gene silencing and inhibiting CXCR4 to improve renal function and reduce renal damage.[6]. Here, CXCR4 is linked to acute kidney injury.